Clinical Trial Update: Study Evalutating the Pharmacokinetics (PK) and Safety of a Single Dose of Desvenlafaxine Sustained Release (DVS SR) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the pharmacokinetics and safety of a single dose of Desvenlafaxine Sustained Release (DVS SR) in major depressive disorder; the trial h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Desvenlafaxine Sustained-Release (DVS-SR) (desvenlafaxine)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Depressive Disorder, Major | Phase 1 | Status: COMPLETED